Improved glycaemic control and treatment satisfaction with a simple wearable 3‐day insulin delivery device among people with Type 2 diabetes
Diabetic Medicine2018Vol. 35(10), pp. 1448–1456
Citations Over TimeTop 20% of 2018 papers
Julia K. Mader, Leslie C. Lilly, Felix Aberer, Tina Poettler, Don Johns, Michael Trautmann, Jay Warner, Thomas R. Pieber
Abstract
Adults with Type 2 diabetes were safely transitioned from insulin injections to the PAQ and had significantly improved glycaemic control and treatment satisfaction with insulin therapy. (ClinicalTrials.gov identifiers: NCT02158078 & NCT02419859).
Related Papers
- → A Patient-Specific Polylactic Acid Bolus Made by a 3D Printer for Breast Cancer Radiation Therapy(2016)88 cited
- → Effects of Insulin and Glucose on Cultured Rat Hepatocyte Gene Expression(1987)23 cited
- → The early phase of insulin release in man — a new method for quantitative analysis(1977)1 cited
- → Biological activity of some insulin derivatives(1981)
- → DOES ABNORMAL ESOPHAGEAL FUNCTION OCCUR IN PATIENTS WITH NUTCRACKER ESOPHAGUS?(2004)